Company Filing History:
Years Active: 2019
Title: Michael Geier: Innovator in ACC Inhibition
Introduction
Michael Geier is a notable inventor based in Foster City, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that inhibit Acetyl CoA Carboxylase (ACC). His work is crucial for advancing treatments for ACC-mediated diseases.
Latest Patents
Geier holds a patent for "Solid forms of a thienopyrimidinedione ACC inhibitor and methods for production thereof." This invention provides solid forms of compounds that are useful as inhibitors of ACC, along with methods for their production and application in treating related diseases. He has 1 patent to his name.
Career Highlights
Throughout his career, Michael Geier has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Gilead Apollo, LLC and Gilead Sciences, Inc. His experience in these organizations has allowed him to contribute to significant advancements in drug development.
Collaborations
Geier has collaborated with esteemed colleagues, including Selcuk Calimsiz and Geraldine C. Harriman. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Michael Geier's innovative work in ACC inhibition showcases his dedication to improving healthcare through scientific advancements. His contributions are vital for the ongoing development of effective treatments for ACC-mediated diseases.